Is Familial Mediterranean Fever a thrombotic disease or not?


The aim of our study was to show how the progression and severity of Familial Mediterranean Fever (FMF) is affected by procoagulant activity and alterations in the markers of thrombosis and fibrinolysis. The study cohort comprised 64 FMF patients who were classified as attack-free patients (Group 1; n = 34 patients, aged 3–19 years) and attack patients… (More)
DOI: 10.1007/s00431-007-0475-2


5 Figures and Tables